Tega Industries Limited — Investor Meet, 21-11-2024: Analysts/Institutional Investor Meet/Con. Call Updates

1. **Financial Performance**: Tega Industries Limited reported total group revenues for the half-year at ₹718 crores, reflecting a 9% increase year-over-year. EBITDA stood at ₹124 crores, with a margin of 17%. In Q2 FY '25, revenue was ₹367 crores, down from ₹380 crores in Q2 FY '24, resulting in an EBITDA of ₹48 crores and a margin of 13%. Key challenges included shipment delays and contract accounting adjustments leading to a one-time expense of ₹17-20 crores impacting margins.

2. **Future Outlook and Growth Drivers**: Management indicated ongoing confidence in achieving a 15% revenue growth target for FY '25 despite current shipment delays, attributing expected recovery in performance to strengthened demand for consumables, especially driven by copper and gold price dynamics tied to global economic factors.

3. **Order Book and Operational Updates**: The order book totals ₹605 crores as of September 2024, providing a solid foundation for revenue recognition in H2. Delays in payments and project inspections impacted recent sales, but management anticipates recovery.

4. **Analyst Q&A Insights**: Analysts focused on the decline in gross and EBITDA margins. Management clarified that the margin drop resulted from temporary accounting issues rather than structural weaknesses. Insights suggest an expected normalisation of margins moving into Q3 as the one-time charges are not expected to recur.

5. **Market or Regulatory Updates**: No specific regulatory issues were discussed; however, geopolitical factors affecting supply chains were noted as a risk. Management expressed that ongoing operations could be affected by delays in global supply chains.

6. **Strategic Focus Areas**: Management emphasized sustainability and the integration of ESG practices in their operations, aligning strategic efforts with growing market demands for environmentally responsible manufacturing.

7. **Investor Insight**: These results reflect a resilient financial foundation despite short-term challenges. Given the firm order backlog and management's strategic outlook, the financial health supports a positive sentiment, deeming it more favorable for a ‘buy’ than a hold, particularly on recovering margins and growth forecasts.